JP2012516349A5 - - Google Patents

Download PDF

Info

Publication number
JP2012516349A5
JP2012516349A5 JP2011548297A JP2011548297A JP2012516349A5 JP 2012516349 A5 JP2012516349 A5 JP 2012516349A5 JP 2011548297 A JP2011548297 A JP 2011548297A JP 2011548297 A JP2011548297 A JP 2011548297A JP 2012516349 A5 JP2012516349 A5 JP 2012516349A5
Authority
JP
Japan
Prior art keywords
alkyl
haloalkyl
halogen
het
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011548297A
Other languages
English (en)
Japanese (ja)
Other versions
JP5658688B2 (ja
JP2012516349A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/022411 external-priority patent/WO2010088392A1/en
Publication of JP2012516349A publication Critical patent/JP2012516349A/ja
Publication of JP2012516349A5 publication Critical patent/JP2012516349A5/ja
Application granted granted Critical
Publication of JP5658688B2 publication Critical patent/JP5658688B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011548297A 2009-01-28 2010-01-28 カルボキサミド化合物およびその使用方法 Expired - Fee Related JP5658688B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14798209P 2009-01-28 2009-01-28
US61/147,982 2009-01-28
PCT/US2010/022411 WO2010088392A1 (en) 2009-01-28 2010-01-28 Carboxamide compounds and methods for using the same

Publications (3)

Publication Number Publication Date
JP2012516349A JP2012516349A (ja) 2012-07-19
JP2012516349A5 true JP2012516349A5 (https=) 2013-03-14
JP5658688B2 JP5658688B2 (ja) 2015-01-28

Family

ID=42061132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011548297A Expired - Fee Related JP5658688B2 (ja) 2009-01-28 2010-01-28 カルボキサミド化合物およびその使用方法

Country Status (17)

Country Link
US (2) US8362235B2 (https=)
EP (1) EP2391616B1 (https=)
JP (1) JP5658688B2 (https=)
KR (1) KR101693061B1 (https=)
CN (1) CN102365275B (https=)
AU (1) AU2010208247B2 (https=)
BR (1) BRPI1007287B8 (https=)
CA (1) CA2750835C (https=)
EA (1) EA022083B1 (https=)
ES (1) ES2581678T3 (https=)
IL (1) IL214203A (https=)
MX (1) MX2011007639A (https=)
NZ (1) NZ594556A (https=)
SG (1) SG172974A1 (https=)
UA (1) UA106600C2 (https=)
WO (1) WO2010088392A1 (https=)
ZA (1) ZA201105215B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010011288A (es) 2008-04-23 2010-11-09 Rigel Pharmaceuticals Inc Compuestos de carboxamida para el tratamiento de trastornos metabolicos.
WO2011123681A1 (en) 2010-03-31 2011-10-06 Rigel Pharmaceuticals, Inc. Methods for using carboxamide, sulfonamide and amine compounds
BR112013002112B1 (pt) 2010-07-29 2021-04-06 Rigel Pharmaceuticals, Inc. Composto, composição farmacêutica, e, uso de um composto, ou de um respectivo sal farmaceuticamente aceitável, ou de uma composição
US9005909B2 (en) 2011-01-06 2015-04-14 Rigel Pharmaceuticals, Inc. Whole blood assay for measuring AMPK activation
US9409884B2 (en) 2012-02-01 2016-08-09 Rigel Pharmaceuticals, Inc. 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
JP6064062B2 (ja) 2013-03-15 2017-01-18 ファイザー・インク Ampkを活性化させるインダゾール化合物
WO2015048547A2 (en) * 2013-09-26 2015-04-02 Rigel Pharmaceuticals, Inc. Methods for using and biomarkers for ampk-activating compounds
US20160214967A1 (en) 2013-09-30 2016-07-28 The University Of Tokyo Activator of adiponectin receptor
CN111787916B (zh) 2018-01-11 2023-09-05 森陶鲁斯治疗公司 用于治疗疾病的二氢神经酰胺去饱和酶抑制剂
US12194023B2 (en) 2018-11-29 2025-01-14 The Research Foundation For The State University Of New York Compositions and methods for modular control of bioorthogonal ligation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
KR100579792B1 (ko) * 1998-05-13 2006-05-12 동화약품공업주식회사 신규 2,5-피리딘디카복실산 유도체
AU2001287898A1 (en) * 2000-09-22 2002-04-02 Stephen Garland Pyrazolopyridines and pyrazolopyridazines as antidiabetics
TW200503994A (en) * 2003-01-24 2005-02-01 Novartis Ag Organic compounds
US20070142369A1 (en) * 2005-12-21 2007-06-21 Margaret Van Heek Combination of an H3 antagonist/inverse agonist and an appetite suppressant
DE602006021591D1 (de) 2006-12-11 2011-06-09 Genetics Co Inc Aromatische 1,4-DI-Carboxylamide und deren Verwendung
CA2674237C (en) 2006-12-28 2015-11-24 Rigel Pharmaceuticals, Inc. N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
GB0706793D0 (en) * 2007-04-05 2007-05-16 Evotec Ag Compounds
BRPI0820171B8 (pt) 2007-11-16 2021-05-25 Rigel Pharmaceuticals Inc compostos de carboxamida, sulfonamida e amina para distúrbios metabólicos, composição farmacêutica, e, uso dos mesmos
CA2707047C (en) * 2007-12-12 2017-11-28 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
MX2010011288A (es) * 2008-04-23 2010-11-09 Rigel Pharmaceuticals Inc Compuestos de carboxamida para el tratamiento de trastornos metabolicos.
WO2011123681A1 (en) 2010-03-31 2011-10-06 Rigel Pharmaceuticals, Inc. Methods for using carboxamide, sulfonamide and amine compounds

Similar Documents

Publication Publication Date Title
JP2012516349A5 (https=)
JP2011503210A5 (https=)
JP2011506480A5 (https=)
ES2552733T3 (es) Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
JP6388991B2 (ja) キナーゼ阻害剤としてのアミノヘテロアリールベンズアミド
JP2013532692A5 (https=)
EP3101015B1 (en) Heterocyclic sulfonamide derivative and medicine comprising same
JP2011527665A5 (https=)
NO20091681L (no) Modulatorer av glukortikoidreseptoren, AP-1, og/eller NF-kappaB aktivitet og anvendelse derav
JP2010514788A5 (https=)
ES2652664T3 (es) Anilinas sustituidas como antagonistas de CCR(4)
TW202430504A (zh) K他命的前藥及其組成物及用途
TW201024313A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
NO20091620L (no) Boronsyre og estere som inhibitorer av fettsyreamidhydrolaser
JP2006513268A (ja) mGluR1−およびmGluR5−アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
MX2011006550A (es) C5ar antagonistas.
JP2011520832A5 (https=)
JP2013533229A5 (https=)
CN106714793B (zh) 琥珀酸脱氢酶抑制剂(SDHi’s)
JP7600134B2 (ja) 機能性消化管障害及び口腔乾燥症の治療剤及び予防剤
ES2676396T3 (es) Moduladores alostéricos positivos del receptor de acetilcolina nicotínico
CN106699744B (zh) 一种杂环类酰胺衍生物及其制备方法和在药学上的应用
WO2012146067A1 (zh) 1,4-二氢吡啶-3,5-二羧酸酯衍生物及其制备与应用
AU2016254049A1 (en) Oxindole compounds and pharmaceutical compositions thereof
TW201217342A (en) Cyclohexane derivatives